We value your privacy

We use cookies to analyze site usage and improve your experience. You can accept all, reject non-essential, or customize. See our Privacy Policy.

Metabolic · Metabolic peptide (research)

L-Carnitine

L-Carnitine reference image
Drug class
Metabolic peptide (research)
Status
Compounded (503A)
Also known as
carnitine, acetyl l-carnitine, alcar, levocarnitine
Reviewed
2026-06-01 · Dr. Ana Lisa Carr, MD

What L-Carnitine is studied for

  • Fatty acid oxidation (research)
  • Energy production (research)
  • Exercise recovery (research)

Mechanism of action

L-Carnitine is being studied in the metabolic category. Amino acid derivative shuttling fatty acids into mitochondria for energy. Mechanism of action varies by study model; refer to the kindr clinical library for a deeper writeup.

Frequently asked questions

What is L-Carnitine?

L-Carnitine is a metabolic peptide. Amino acid derivative shuttling fatty acids into mitochondria for energy.

What is L-Carnitine studied for?

Published research has examined L-Carnitine for fatty acid oxidation, energy production, exercise recovery. Human clinical evidence varies by indication.

Is L-Carnitine FDA-approved?

No. L-Carnitine is not FDA-approved for the indications listed. It is available compounded by 503A pharmacies under clinician supervision, or for international research use only on this catalog.

How is L-Carnitine used in research?

Protocols vary by study. L-Carnitine is typically administered subcutaneously in research settings. No validated human therapeutic dose exists outside FDA-approved indications.

What are the known risks?

Long-term human safety data for L-Carnitine is limited. Theoretical risks vary by mechanism. Any human use should be supervised by a licensed clinician.

International research catalogView L-Carnitine in the kindr Peptides Shop →

Related peptides in Metabolic

SemaglutideGLP-1 for weight, appetite, and metabolic health.TirzepatideDual GLP-1 / GIP for next-generation metabolic care.RetatrutideNext-generation triple agonist (GLP-1 / GIP / glucagon) in active research.AOD-9604hGH fragment targeting fat metabolism without affecting IGF-1.CagrilintideLong-acting amylin analog — often paired with semaglutide (CagriSema).AICARAMPK activator studied for endurance and metabolic efficiency.
Research & medical disclosure. This page is educational reference content reviewed by a licensed physician. It is not medical advice and does not establish a clinician–patient relationship. Peptides offered on the kindr Peptides Shop are sold for in vitro laboratory research purposes only and ship internationally — not to the United States. For U.S. clinical care, use the kindr Longevity intake.